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24 ABSTRACT 
 
25 BACKGROUND 
 
26 It is plausible that night shift work could affect breast cancer risk, possibly by melatonin suppression 
 
27 or circadian clock disruption, but epidemiological evidence is inconclusive. 
 
28 METHODS 
 
29 Using serial questionnaires from the Generations Study cohort we estimated hazard ratios (HR) and 
 
30 95% confidence intervals (95%CI) for breast cancer in relation to being a night shift worker within 
 
31 the last 10 years, adjusted for potential confounders. 
 
32 RESULTS 
 
33 Among 102 869 women recruited 2003–2014, median follow-up 9.5 years, 2059 developed invasive 
 
34 breast cancer. The HR in relation to night shift work was 1.00 (95%CI: 0.86–1.15). There was a 
 
35 significant trend with average hours of night work per week (P=0.035), but no significantly raised 
 
36 risks for hours worked per night, nights worked per week, average hours worked per week, 
 
37 cumulative years of employment, cumulative hours, time since cessation, type of occupation, age 
 
38 starting night shift work, or age starting in relation to first pregnancy. 
 
39 CONCLUSIONS 
 
40 The lack of overall association, and no association with all but one measure of dose, duration, and 
 
41 intensity in our data, does not support an increased risk of breast cancer from night shift work in 
 
42 women. 
 
43 KEY WORDS: breast cancer, cohort study, night shift work, risk 
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44 BACKGROUND 
 
 
45 Over 30 years ago it was proposed that suppression of the pineal hormone melatonin by 
 
46 exposure to electric light at night could increase risk of breast cancer (1). In 2007 an International 
 
47 Agency for Research on Cancer working group concluded that there was limited evidence in humans 
 
48 for the carcinogenicity of shift work that involves night work but overall shift work that involves 
 
49 circadian disruption is probably carcinogenic to humans (Group 2A) (2). There are biological reasons 
 
50 why night shift work may increase risk of breast cancer by suppression of melatonin (the ‘melatonin 
 
51 hypothesis’) (3) or disruption of internal ‘body clocks’ (circadian clocks) (4), however, findings from 
 
52 epidemiological cohort (5-16) and case-control (17-22) studies have been inconclusive. Most (17-21, 
 
53 23-25), but not all (15), meta-analyses suggest night shift work may be associated with a modestly 
 
54 raised risk of breast cancer in women (26, 27). But the association is weaker when limited to cohort 
 
55 studies (18-21, 25, 27), the type of night shift work and exposure definitions have varied from study 
 
56 to study (28), and no clear dose-response relationship has been demonstrated (26, 27). 
 
57 The most recent meta-analysis of all prospective studies including three previously 
 
58 unpublished cohorts concluded that night shift work has little or no effect on breast cancer 
 
59 incidence (15), but this has been challenged (29-31). It has been suggested that recent exposure 
 
60 (29-32), initiating night work at young ages (16, 30, 31) or before first pregnancy (33, 34), and risk 
 
61 among pre-menopausal women for estrogen receptor (ER) positive, progesterone receptor (PR) 
 
62 positive, or human epidermal growth factor-receptor 2 (HER2) positive tumours (14, 16, 34, 35) may 
 
63 be relevant, but the evidence is inconclusive. We therefore examined risk of breast cancer in 
 
64 relation to timing of night shift work and receptor status, in a large UK cohort study that has not 
 
65 been included in previous meta-analyses, using detailed questionnaire information at recruitment 
 
66 and during follow-up, with adjustment for potentially confounding factors. 
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67 MATERIALS AND METHODS 
 
68 The Generations Study (GS) is a cohort study of >113 700 women aged 16 or older from the 
 
69 United Kingdom. Questionnaire information and informed consent was gained at recruitment since 
 
70 2003 (36). The first follow-up questionnaire 2½ years after recruitment was completed by 99% of 
 
71 non-deceased participants, a second six years after recruitment by 97%, and a third 9½ years after 
 
72 recruitment by 96% of those recruited long enough ago to have entered this phase of follow-up. 
 
73 Breast and other cancers occurring in the cohort were identified from recruitment and 
 
74 follow-up questionnaires and spontaneous reports to the study centre. Spontaneous reports 
 
75 occurred when a woman contacted us and told us about her cancer diagnosis. For those lost to 
 
76 questionnaire follow-up we ascertained cancers from linkage to National Health Service Central 
 
77 Registers (NHSCR) which provides information on vital status, cancer diagnosis and site (37). 
 
78 Confirmation of diagnosis was obtained from cancer registries in the United Kingdom, NHSCR 
 
79 linkage, pathology reports, and correspondence with patients’ general practitioners. 
 
80 Information on risk factors for breast cancer was obtained from recruitment and follow-up 
 
81 questionnaires. Because we had collected ages or dates at which certain events or changes in 
 
82 lifestyle occurred, we were able to conduct analyses using time-updated alcohol use, parity, oral 
 
83 contraceptive use, menopausal hormone therapy (MHT) use, and menopausal status, at the ages 
 
84 these events or changes occurred through to the second follow-up questionnaire. We also updated 
 
85 post-menopausal body mass index (BMI) at the date of the second follow-up questionnaire. 
 
86 In relation to night shift work, women were asked in the recruitment questionnaire: “Over 
 
87 the last ten years, have you had any jobs that regularly involved work in the late evening or night 
 
88 (between 10pm and 7am)”, and we collected information on type of job, year starting and ending, 
 
89 average number of nights per week working at night or late evening, and average number of hours 
 
90 worked between 10pm and 7am for each such episode of work. The same information on night 
 
91 work, but covering the period from recruitment to the second follow-up questionnaire, was 
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92 collected at this follow-up six years after recruitment. When analysing type of occupation in which 
 
93 night shift work occurred, if a woman reported different types of night work occupation 
 
94 concurrently during a time period, we counted only the type of work that she had done the most, so 
 
95 that we could allocate her to a single occupation at any one time. If the hours per night or nights per 
 
96 week of night work changed during a period of night work, we took an average of these night work 
 
97 intensity measures weighted by the number of years at each intensity. We did not ask about night 
 
98 shift work in the next follow-up questionnaire, 9½ years after recruitment. 
 
99 To analyse breast cancer risk in relation to being a night shift worker in the last 10 years we 
 
100 updated night shift work status, and cumulative duration and time since cessation in single year 
 
101 increments, through to the six year follow-up. After this point we assumed that women who had 
 
102 never been a night shift worker, or had ceased, did not commence new night work, and that women 
 
103 who were in current night work continued at the same intensity, frequency, and duration through to 
 
104 the end of analytic follow-up. Because our questionnaires only solicited information on night shift 
 
105 work history which, at least in part, had been undertaken in the last 10 years we did not count 
 
106 information from night shift histories that ended completely more than 10 years ago (i.e. when 
 
107 women volunteered more information than requested) because we deemed this would be 
 
108 incomplete or missing for some women. Therefore we were able to analyse comprehensive 
 
109 information on night shift exposures more than ten years ago that continued into the last 10 year 
 
110 period, but for exposures based on work history that ended before this 10 year period our analysis 
 
111 would be less complete. 
 
112 Statistical analysis 
 
113 The current analytic cohort is based on all women who were recruited to the study during 
 
114 June 2003–December 2014 without prior invasive or in-situ breast cancer or other malignancy 
 
115 except non-melanoma skin cancer, or prior mastectomy, and who did not report being registered as 
 
116 blind or partially sighted because of the possible association between blindness, melatonin, and 
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117 breast cancer risk (38). The recruitment cut-off at December 2014 was selected because at the time 
 
118 of analysis the second follow-up was practically complete for this group of recruits and all women 
 
119 would have in principle been able to reach the minimum follow-up of 2½ years associated with the 
 
120 first follow-up questionnaire. Women entered risk at their date of recruitment and were censored 
 
121 at the earliest date of: invasive or in-situ breast cancer; other malignancy except non-melanoma skin 
 
122 cancer; death; or most recent follow-up questionnaire which was dependent on date of recruitment. 
 
123 If the most recent follow-up questionnaire was not completed the censoring date was the date the 
 
124 most recent follow-up questionnaire was due if cancer and vital status were known after this date 
 
125 from NHSCR linkage. If cancer and vital status were not known at this due date this was considered 
 
126 a loss to optimum follow-up and the censoring date was the date of the last completed 
 
127 questionnaire. The data for this analysis was extracted and frozen from our live database on 9-Jan- 
 
128 2019. 
 
129 Left-truncated and right censored Cox proportional hazards regression (39) using attained 
 
130 age as the implicit time scale was used to estimate the hazard ratio (HR) and 95% confidence interval 
 
131 (95%CI) for night shift work and risk of first invasive breast cancer adjusted for potential confounding 
 
132 factors (see footnotes to Tables 2 and 3). We analysed primarily risk in relation to invasive breast 
 
133 cancer so that our results would be comparable with those from the Million Women Study, EPIC- 
 
134 Oxford, and UK Biobank (15), the Nurses Health Studies (16), and other prospective studies (9-11, 
 
135 15), although we also compared HRs for invasive versus in-situ breast cancer. 
 
136 Statistical trends for frequency, intensity, and duration of night work, and time since last 
 
137 night work, were based on discrete time-varying annually updated values. For example if at the time 
 
138 of recruitment a woman had been in night shift work for 5 years her cumulative exposure would be 
 
139 5 years. If she continued night shift work then in the next year of follow-up her cumulative exposure 
 
140 would be updated to 6 years, and so on as long as she continued night shift work. Trends in these 
 
141 time-varying exposures and trend in risk with age starting night work, were assessed using the 
 
142 likelihood ratio test (40). For trend analyses, the groups defined by not being a night shift worker in 
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143 the last 10 years and current night shift worker in analysis of time since cessation were not assigned 
 
144 a zero magnitude but were treated as separate categorical terms, as was the group where the 
 
145 details of night shift work were missing (i.e. trends were only evaluated across those who were 
 
146 exposed but by using indicator variables we included the non-exposed and missing value group in 
 
147 the regression analysis). We stratified by breast cancer risk factors to examine interactions between 
 
148 these risk factors and night shift work, and by ever-use of melatonin supplements (reported at 
 
149 cohort entry). Heterogeneity in HRs by sub-type of breast cancer defined by receptor status, 
 
150 histology, or invasive versus in-situ breast cancer, was assessed using a data augmentation method 
 
151 (41) and Wald test (40). All statistical tests were two-sided and analyses were conducted using 
 
152 Stata/IC version 14.2 (42). 
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153 RESULTS 
 
154 During 2003–2014 a recruitment questionnaire was completed by 102 869 women in the GS 
 
155 who had no previous invasive or in-situ breast cancer or other malignancy except non-melanoma 
 
156 skin cancer. By the censoring date, 1.1% of the women had died. Of the remainder, cancer and vital 
 
157 status was known for 95.3% who had completed the relevant follow-up questionnaire, and a further 
 
158 3.2% from linkage to the NHSCR. The remaining 0.4% were lost to follow-up and censored at the 
 
159 date of an earlier returned questionnaire. The last follow-up and censoring date was 27th March 
 
160 2018. 
 
161 Table 1 presents descriptive characteristics, at recruitment, of the cohort members eligible 
 
162 for analysis, by night work status. The median age at recruitment was 45 years (inter-quartile range: 
 
163 35–55). Among participants 17.5% reported being a night shift worker within the last 10 years. 
 
164 There were significant variations in the percentage of night shift workers in relation to all but one 
 
165 demographic or descriptive characteristic in the table (all Pheterogeneity<0.0001, except for pre- 
 
166 menopausal oral contraceptive use, P=0.13). The proportion reporting ever being a night shift 
 
167 worker in the 10 years before recruitment was greater for women who were younger, pre- 
 
168 menopausal, higher BMI at age 20, did not report family history of breast cancer or personal history 
 
169 of benign breast disease, lived in less affluent neighbourhoods, nulliparous, ex-drinkers of alcohol, 
 
170 current smokers, higher levels of physical activity, higher BMI at post-menopausal ages, current 
 
171 users of MHT, and those not reporting ever use of melatonin supplement. 
 
172 During 880 864 person-years (median 9.5 years) of follow-up 2059 invasive breast cancers 
 
173 occurred, of which 2041 were confirmed through national cancer registration or medical records, 
 
174 and the remainder (n=18) were self-reported mostly with treatment or other details that implied 
 
175 breast cancer, e.g. information on receptor status. ER status data were available for 96.6%, and of 
 
176 these 84.3% were ER-positive. Invasive ductal carcinoma accounted for 78.2%, and lobular for 
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177 16.4%, of tumours. Further descriptive characteristics of the breast cancer cases are given in 
 
178 Supplementary Table 1. 
 
179 The HR for invasive breast cancer in relation to being a night shift worker within the last 10 
 
180 years was 0.98 (95%CI: 0.85–1.14; P=0.80) with adjustment only for attained age, and 1.00 (95%CI: 
 
181 0.86–1.15; P=0.96) with adjustment for additional potentially confounding factors (Table 2). There 
 
182 were no significantly raised risks in relation to hours worked per night (Ptrend= 0.62), nights per week 
 
183 on night shift (Ptrend=0.066), cumulative years of employment as a night shift worker (Ptrend=0.51), or 
 
184 cumulative hours of night shift work (Ptrend=0.51), but there was a significant positive trend with 
 
185 average hours per week, adjusted for age only (Ptrend=0.038) or fully adjusted (Ptrend=0.035) (Table 2). 
 
186 There were no significantly raised risks with being a night shift worker in the last 10 years by 
 
187 type of occupation nor was there evidence for heterogeneity (Table 3; P=0.20). There were no 
 
188 significant associations with age started night shift work (Ptrend=0.89), whether night shift work 
 
189 started before (P=0.73) or after (P=0.90) first pregnancy, or by time since last worked night shifts 
 
190 (Ptrend=0.38). When we restricted our analyses to women at recruitment who either reported being 
 
191 in a paid or self-employed job (n=69 942), student (n=3599), unemployed (n=789), or retired (n=15 
 
192 711) our results were essentially the same (Supplementary Tables 2 and 3). We examined by 
 
193 stratification, interactions between risk of breast cancer and night shift work by selected risk factors 
 
194 for breast cancer, and for ever-use of melatonin supplement before recruitment, but found no 
 
195 significant associations or interactions (Supplementary Table 4). 
 
196 We also stratified by menopausal status and examined risk in relation to being a night shift 
 
197 worker in the last 10 years and average hours per week on night shift but found no significant 
 
198 associations, trends, or interactions (Supplementary Table 5). Nor were there significantly raised 
 
199 risks in relation to night shift work by receptor status of breast cancer (ER, PR, HER2) or histological 
 
200 type (Supplementary Table 5). Further sub-division by menopausal status and sub-type of breast 
 
201 cancer is shown in Supplementary Table 6. No significantly raised risks were seen by sub-type for 
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202 pre-menopausal women, although there were some significant associations and trends seen in post- 
 
203 menopausal women for PR-positive, HER2-negative, and lobular tumours, but with no consistent 
 
204 pattern. Finally, when we analysed risk in relation to in-situ breast cancer (n=411 cases) the 
 
205 adjusted HR for night shift work in the last 10 years was 1.16 (95%CI: 0.85–1.57; P=0.35), with no 
 
206 significant heterogeneity between invasive and in-situ breast cancer (P=0.39). 
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207 DISCUSSION 
 
208 In our detailed analysis of night shift work and risk of breast cancer we examined relative 
 
209 risks in relation to a number of aspects of being a night shift worker in the last 10 years, and with 
 
210 few exceptions, most were not statistically significant. We found no evidence for an overall increase 
 
211 in risk of breast cancer for women who had been night shift workers within the last 10 years, or by 
 
212 hours worked per night, nights worked per week, average hours worked per week, cumulative years 
 
213 of employment, cumulative hours, or time since cessation of such work. We found no significantly 
 
214 raised risks with type of night shift occupation, by age at starting night shift work, or by age starting 
 
215 in relation to first pregnancy. Increased risk has been reported previously for night shift work 
 
216 specifically among nurses (17), in particular those engaged in rotating night shift work (6, 7, 43), but 
 
217 we found no increased risk for nurses undertaking night shift work, nor did the Million Women Study 
 
218 (15), although neither we nor the Million Women Study explicitly examined rotating shift work. 
 
219 The Nurses’ Health Studies reported raised risks for night work of >20 years duration (6, 7), 
 
220 but this has not been seen in other cohorts (9, 11-13, 15) or the recent comprehensive meta-analysis 
 
221 of prospective studies (15). A previous dose-response meta-analysis of cohort and case-control 
 
222 studies did report a significant trend with duration (19) whereas another did not (17), so the 
 
223 literature is inconclusive on this. We found no association with duration in our study, although our 
 
224 data for long durations of night work was limited because our study was focussed on recent night 
 
225 shift work in the last 10 years. One potential interpretation for the raised risk seen with long 
 
226 duration in the Nurses’ Health Studies is that this raised risk relates to night shift work during the 
 
227 period after puberty and before first childbirth, when the breast may be particularly susceptible to 
 
228 adverse changes (16). Such an association has been reported in a case-control study from France 
 
229 (33) but we, and the Nurses’ Health Study-II (16), did not find increased risks with night shift work 
 
230 starting before first pregnancy. We also found no association with age started night shift work, 
 
231 similar to the one other cohort that has reported on this (9). 
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232 We did not find evidence for significant interaction (effect modification) between breast 
 
233 cancer risk factors and night shift work in relation to risk of breast cancer, similar to the Million 
 
234 Women Study (15). However, we found night shift work was positively associated with several 
 
235 characteristics that are associated with breast cancer risk therefore there is scope for confounding. 
 
236 In our study adjusting for these potential confounding factors made no material changes to the 
 
237 results, and adjustment for similar factors in other cohort studies (6, 7, 9, 10, 12, 14-16) generally 
 
238 made little difference to their conclusions (44). But if the confounding association is study specific, 
 
239 or women who engage in night shift work differ in other unidentified ways from those who do not, 
 
240 this may explain why results in the literature have been inconsistent. 
 
241 The only statistically significant association observed in our main analyses in relation to 
 
242 breast cancer and night shift work was a dose-response trend with average hours per week on night 
 
243 shift. A significant trend has previously been reported in a case-control study for hours per week of 
 
244 ‘graveyard’ shift work (i.e. work between 7pm and 9am) in the 10 years before diagnosis (32), and 
 
245 raised risk for ;?20 hours per week in a pooled case-control analysis (22), whereas in a large record 
 
246 linkage cohort study based on Dutch Labor Force Surveys no significant association was seen with a 
 
247 metric based on contractual night working hours (11). There does not appear to be a strong 
 
248 rationale for hours per week on night shift being a risk factor for breast cancer.  We found no 
 
249 significant overall association of risk of breast cancer with being a night shift worker. There was also 
 
250 lack of association with the other measures of dose, duration, and intensity that we analysed. These 
 
251 results from our study and the absence in the literature of an hypothesis for why there should be an 
 
252 association with hours per week but not with other measures of dose, duration, or intensity, and 
 
253 conflicting results from other studies (11, 22, 32) suggest it is possible this is a chance finding in our 
 
254 data. However, unlike traditional carcinogens where cumulative exposure and dose may supersede 
 
255 intensity as a requisite for cause-effect association it is still unclear which exposure ‘domains’ may 
 
256 be important in relation to night shift work (28). 
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257 We found overall no significantly raised risks by menopausal status for ER, PR, HER2, or 
 
258 histological sub-types of breast cancer. Significantly raised risks have been reported for ER-positive 
 
259 (16, 34, 35, 45), ER-negative (46), PR-positive (16, 34, 35, 45), HER2-positive (35), HER2-negative 
 
260 (45), and lobular (34) breast cancer sub-types in particular among pre-menopausal women (14, 16, 
 
261 34, 35) but we did not find any significantly raised risks in pre-menopausal women, overall or by sub- 
 
262 type. We did see raised risks among post-menopausal women, but are uncertain about the 
 
263 interpretation because these occurred in sub-group analyses subject to inflated type-I statistical 
 
264 error. The evidence in the literature for risk by tumour sub-type, and menopausal status, is 
 
265 inconsistent (14, 16, 34, 35, 45, 46) and this may be a reflection of small number of cases in 
 
266 subgroups and lack of statistical power, or that there is no substantive difference by sub-type of 
 
267 breast cancer in relation to night shift work. 
 
268 Our night shift information was gained at recruitment and from follow-up questionnaire six 
 
269 years later but our follow-up for breast cancer extended beyond the six year questionnaire. We 
 
270 updated night shift work up to the six-year questionnaire, and then carried forward the exposure 
 
271 status at that point in time until end of follow-up if this was >6 years. About one-third (31%) of 
 
272 accrued person-years were after the six-year follow-up but 78% of the post six-year follow-up 
 
273 person-years occurred soon after that, within the first three years after that follow-up. So the scope 
 
274 for potential exposure misclassification was therefore less than in cohort studies that implicitly carry 
 
275 forward exposure status from recruitment for everyone because the studies do not have any 
 
276 updated exposure information. The only other study with updated night shift exposure information 
 
277 using repeat questionnaires, The Nurses’ Health Study-II (16), found a significantly raised risk with 
 
278 cumulative duration ;?20 years, but we did not and other cohorts with updated night shift 
 
279 information based on record linkage to employment databases did not find an association overall or 
 
280 with duration (8, 13, 14). 
 
281 Our questions on night shift work only ascertained periods of shift work that took place, or 
 
282 at least ended, during the 10 years before recruitment. We did not collect lifetime history of night 
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283 shift work because we needed to contain the burden of data collection on the recruits to the study, 
 
284 who at recruitment were completing a 44-page questionnaire covering a wide range of breast cancer 
 
285 related topics. Some have suggested that any increased risk associated with night shift work may 
 
286 diminish soon after exposure ceases (22, 30, 31) and as analysed here recent, rather than historic, 
 
287 night shift work may be the most appropriate measure of exposure. However, to the extent that it is 
 
288 longer term or earlier exposures that matter, our analyses would be limited and weaker. 
 
289 An advantage of our study is that we were able to examine a wider range of night shift 
 
290 exposures than most other prospective studies, which were often limited to analyses of duration of 
 
291 night shift. There was little scope for bias from unascertained mortality or exits, or erroneous 
 
292 reporting of breast cancer in our study, because follow-up for vital and breast cancer status was 
 
293 obtained for 99% of participants and confirmation of reported breast cancers for over 99%. Our 
 
294 breast cancer cases were particularly well characterised for histological type and ER status, allowing 
 
295 for analyses by sub-type of breast cancer. Information on PR and HER2 status was less complete 
 
296 because these tests have not been conducted routinely throughout the study period. As breast 
 
297 cancer treatment has advanced, PR testing has become less common and HER2 testing become 
 
298 more common in the UK, but it seems unlikely this would cause major bias in our analyses by sub- 
 
299 type. 
 
300 The interest in night shift work and risk of breast cancer springs from the hypothesis that 
 
301 exposure to light at night may increase risk of breast cancer (1-3). Only this GS cohort (47) and a 
 
302 cohort of California teachers (48) have examined directly, by prospective questionnaire, exposure to 
 
303 indoor light at night in relation to breast cancer risk, rather than outdoor light at night from 
 
304 ecological geographical correlation with environmental data (e.g. from satellite imagery), and both 
 
305 studies fail to find significant associations with indoor light at night. However, the possible 
 
306 association between night shift work and breast cancer remains a public health concern. A 
 
307 substantial proportion of women in the general population are exposed to night shift work (28, 49) 
 
308 and even a modestly increased risk could lead to considerable numbers of breast cancer cases (49- 
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309 51) if there were a causal association. We did find a statistically significant trend with average hours 
 
310 per week on night shift. But in the absence of an association between breast cancer risk and night 
 
311 shift work overall, or by other measures of dose, duration, or intensity, in our study, and no evidence 
 
312 for association from the most recent and comprehensive meta-analysis (not including the 
 
313 Generations Study) of prospective studies (15), our finding of a significant trend on its own does not 
 
314 provide strong support for a real causal association. Our data overall do not provide evidence for an 
 
315 increased risk of breast cancer with night shift work. 
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TABLE 1: Characteristics at recruitment of 102,869 women from the Generations Study, by night shift work* during the 10 years 
before recruitment to cohort 
 
Characteristic 
Ever been a night shift worker during the 10 years before recruitment 
to cohort 
 
Total 
 
 No   Yes  Yes  
N %  N % %† N % 
Year of birth         
1908–1939 5771 6.8  136 0.8 2.3 5907 5.7 
1940–1949 20174 23.8  1308 7.3 6.1 21482 20.9 
1950–1959 21816 25.7  2930 16.3 11.8 24746 24.1 
1960–1969 19066 22.5  4665 25.9 19.7 23731 23.1 
1970–1998 18061 21.3  8942 49.7 33.1 27003 26.2 
Year of recruitment         
2003–2005 27481 32.4  6272 34.9 18.6 33753 32.8 
2006-–2007 40096 47.2  8293 46.1 17.1 48389 47.0 
2008–2014 17311 20.4  3416 19.0 16.5 20727 20.1 
Age at recruitment (years)         
16–34 15142 17.8  8037 44.7 34.7 23179 22.5 
35–44 18295 21.6  4807 26.7 20.8 23102 22.5 
45–54 21112 24.9  3281 18.2 13.4 24393 23.7 
55–64 22277 26.2  1602 8.9 6.7 23879 23.2 
65–74 7088 8.3  244 1.4 3.3 7332 7.1 
75–102 
BMI at recruitment (kg/m
2
) 
974 1.1  10 0.1 1.0 984 1.0 
<20.0 5398 6.4  1278 7.1 19.1 6676 6.5 
20.0–<22.5 18074 21.3  3897 21.7 17.7 21971 21.4 
22.5–<25.0 23022 27.1  4457 24.8 16.2 27479 26.7 
25.0–<30.0 24817 29.2  4832 26.9 16.3 29649 28.8 
;30.0 11177 13.2  2844 15.8 20.3 14021 13.6 
Missing 
BMI at age 20* (kg/m
2
) 
2400 2.8  673 3.7 21.9 3073 3.0 
<18.5 7075 8.3  1198 6.7 14.5 8273 8.0 
18.5–<20.0 16275 19.2  2822 15.7 14.8 19097 18.6 
20.0–<22.5 32370 38.1  6219 34.6 16.1 38589 37.5 
22.5–<25.0 17435 20.5  4200 23.4 19.4 21635 21.0 
;25.0 7817 9.2  2807 15.6 26.4 10624 10.3 
age < 20 at entry 982 1.2  220 1.2 18.3 1202 1.2 
Missing 2934 3.5  515 2.9 14.9 3449 3.4 
Family history of breast cancer at recruitment 
None reported 71348 84.0 15592 86.7 17.9 86940 84.5 
Yes 13540 16.0 2389 13.3 15.0 15929 15.5 
History if benign breast disease at recruitment 
None reported 68014 80.1 15033 83.6 18.1 83047 80.7 
Yes 16874 19.9 2948 16.4 14.9 19822 19.3 
Living in affluent neighbourhood‡        
More affluent 38913 45.8 5723 31.8 12.8 44636 43.4 
Less affluent 45987 54.2 12258 68.2 21.0 58233 56.6 
Parity at recruitment        
Nulliparous 20798 24.5 8001 44.5 27.8 28799 28.0 
Parous 64090 75.5 9980 55.5 13.5 74070 72.0 
  
Premenopausal oral contraceptive use 
 
Post-menopausal § 39789 --- 3251 --- --- 43040 --- 
No 6364 14.1 2006 13.6 24.0 8370 14.0 
Yes 38735 85.9 12724 86.4 24.7 51459 86.0 
Regular alcohol consumption        
Never 16928 19.9 3204 17.8 15.9 20132 19.6 
Current 57364 67.6 11959 66.5 17.3 69323 67.4 
Ex-drinker 10596 12.5 2818 15.7 21.0 13414 13.0 
Regular cigarette smoking        
Never 55236 65.1 10740 59.7 16.3 65976 64.1 
Current 5847 6.9 2544 14.1 30.3 8391 8.2 
Ex-smoker 23805 28.0 4697 26.1 16.5 28502 27.7 
Physical activity (by quartile of MET) 
<30 21913 25.8 3871 21.5 15.0 25784 25.1 
30–<51 21726 25.6 4145 23.1 16.0 25871 25.1 
51–<83 21044 24.8 4275 23.8 16.9 25319 24.6 
83+ 20064 23.6 5669 31.5 22.0 25733 25.0 
Missing 
Postmenopausal BMI (kg/m
2
) 
141 0.2 21 0.1 13.0 162 0.2 
Pre-menopausal § 45099 --- 14730 --- --- 59829 --- 
<20.0 1511 3.8 96 3.0 6.0 1607 3.7 
20.0–<22.5 6481 16.3 450 13.8 6.5 6931 16.1 
22.5–<25.0 10715 26.9 769 23.7 6.7 11484 26.7 
25.0–<30.0 13244 33.3 1092 33.6 7.6 14336 33.3 
30.0+ 5482 13.8 677 20.8 11.0 6159 14.3 
Missing 2356 5.9 167 5.1 6.6 2523 5.9 
Postmenopausal hormone therapy use 
Pre-menopausal § 45099 --- 14730 --- --- 59829 --- 
Never used 22696 57.0 1795 55.2 7.3 24491 56.9 
Ex-user 9944 25.0 707 21.7 6.6 10651 24.7 
Current user 6324 15.9 675 20.8 9.6 6999 16.3 
User, status unknown 825 2.1 74 2.3 8.2 899 2.1 
Ever used melatonin supplements before recruitment 
No 82010 96.6 17487 97.3 17.6 99497 96.7 
Yes 2878 3.4 494 2.7 14.7 3372 3.3 
Total 84888 100.0 17981 100.0 17.5 102869 100.0 
BMI: Body Mass Index; MET: Metabolic Equivalent to Task 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am)? 
† Row percentage: 
‡ Based on ACORN score, a socio-demographic neighbourhood based score 
§ Not included in column percentage for distribution 
  
TABLE 2: Relative risk of invasive breast cancer in relation to ever being a night shift worker* in last 10 years, by frequency, 
intensity, and duration of night shift work 
 
Cases† 
Person-years Age adjusted Full adjustment‡ 
  
(per 100,000) HR 95% CI P -value HR 95% CI P -value 
Being a night shift worker within the last 10 years 
 
None 1845 738.4 1.00 Baseline  1.00 Baseline  
Yes 214 142.5 0.98 0.85–1.14 0.80 1.00 0.86–1.15 0.96 
Average hours worked per night 
None 1845 738.4 1.00 Baseline  1.00 Baseline  
<7 hours 91 66.4 1.05 0.85–1.30 0.66 1.04 0.84–1.28 0.74 
7+ hours 103 65.1 0.93 0.76–1.14 0.48 0.96 0.78–1.17 0.68 
Unknown 20 11.0 0.98 0.63–1.52 0.93 1.02 0.65–1.58 0.94 
Trend§:     0.44   0.62 
Average nights per week on night shift 
None 1845 738.4 1.00 Baseline  1.00 Baseline  
<4 152 104.9 0.95 0.80–1.12 0.52 0.96 0.81–1.14 0.65 
4–7 55 32.5 1.16 0.89–1.52 0.28 1.18 0.90–1.55 0.23 
Unknown 7 5.1 0.70 0.33–1.48 0.35 0.70 0.33–1.47 0.35 
Trend§:     0.073   0.066 
Average hours per week on night shift 
None 1845 738.4 1.00 Baseline  1.00 Baseline  
<10 70 56.3 0.88 0.69–1.12 0.31 0.88 0.69–1.12 0.29 
10–<20 61 38.9 1.06 0.82–1.37 0.67 1.07 0.83–1.39 0.60 
20–<30 35 20.5 1.02 0.73–1.43 0.90 1.05 0.75–1.48 0.76 
30+ 26 13.5 1.20 0.81–1.77 0.36 1.27 0.86–1.87 0.24 
Unknown 22 13.3 0.88 0.58–1.34 0.54 0.91 0.60–1.38 0.65 
Trend§:     0.038   0.035 
Cumulative years of employment as night shift worker 
None 1845 738.4 1.00 Baseline  1.00 Baseline  
<10 89 87.0 0.90 0.73–1.12 0.36 0.92 0.74–1.14 0.44 
10–<20 65 33.7 1.07 0.83–1.37 0.61 1.09 0.85–1.40 0.51 
20–<30 36 14.9 0.96 0.69–1.34 0.81 0.97 0.70–1.35 0.85 
30+ 24 6.9 1.12 0.75–1.67 0.59 1.12 0.75–1.69 0.57 
Trend§:     0.49   0.51 
Cumulative hours of night shift work (10,000 hours) 
None 1845 738.5 1.00 Baseline  1.00 Baseline  
0–<1 103 83.0 1.00 0.82–1.23 0.99 1.00 0.82–1.23 0.98 
1–<2 36 18.7 1.01 0.73–1.41 0.95 1.04 0.74–1.44 0.83 
2–<3 22 8.1 1.21 0.80–1.85 0.37 1.24 0.82–1.90 0.31 
3+ 21 7.4 1.05 0.68–1.61 0.84 1.07 0.70–1.66 0.75 
Unknown 32 25.3 0.78 0.55–1.10 0.16 0.79 0.56–1.13 0.20 
Trend§: 0.57 0.51 
HR: Hazard Ratio; CI: Confidence Interval 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am)? 
† Number of breast cancer cases 
  
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 
1960–69, 1970–96); benign breast disease (yes, no); family history of breast cancer in 1st degree relatives (yes, no); socio-economic score (ACORN score as 
trend, missing); birth weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, 
missing); age at first pregnancy (trend, missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, 
no); alcohol consumption (never regular, trend current drinker 1-– <60g/day, current drinker 60+g/day, past drinker, drinker with unknown details); age 
started smoking (never, <17, 17_9, 20+, unknown); physical activity (log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, 
missing); menopausal hormone therapy use (never used, ex-user, current estrogen only user, current estrogen plus progestogen user, current user of 
other types, missing); menopausal status (pre- or post-menopausal) and age at menopause (trend, missing). 
§ Trend evaluated over those doing night shift work, based on time-varying annually updated values 
  
TABLE 3: Relative risk of invasive breast cancer in relation to ever being a night shift worker* in last 10 years, by type of work, age 
started, timing of first pregnancy, and time since last night shift work 
Person-years Age adjusted Full adjustment‡ 
Ca ses† 
(per 100,000) HR 95% CI P -value  HR 95% CI P -value 
Type of night shift work in last 10 years         
None 1845 763.4 1.00 Baseline   1.00 Baseline  
Nurse 83 51.1 0.83 0.66–1.03 0.092  0.85 0.68–1.07 0.17 
Waitress 10 24.5 0.60 0.32–1.13 0.11  0.61 0.33–1.15 0.13 
Office/shops 29 14.3 1.32 0.92–1.91 0.14  1.35 0.93–1.95 0.11 
Health Carer 22 9.1 1.29 0.85–1.97 0.23  1.42 0.93–2.17 0.11 
Technical 18 8.4 1.37 0.86–2.18 0.18  1.28 0.81–2.05 0.29 
Emergency services, armed 13 7.0 1.37 0.79–2.37 0.26  1.31 0.76–2.27 0.34 
forces, air crew          
Manual work 8 4.6 1.10 0.55–2.21 0.79  1.12 0.56–2.25 0.74 
Doctor/GP 7 8.3 0.85 0.40–1.78 0.66  0.78 0.37–1.65 0.52 
Other 24 20.7 0.99 0.66–1.49 0.98  0.97 0.65–1.45 0.88 
Heterogeneity:     0.18    0.20 
Age started night work (years)          
None 1845 738.4 1.00 Baseline   1.00 Baseline  
<25 71 72.7 1.02 0.80–1.31 0.86  1.03 0.80–1.32 0.82 
25–34 45 36.1 0.82 0.61–1.11 0.20  0.84 0.62–1.14 0.26 
35–44 63 20.7 1.21 0.94–1.56 0.13  1.24 0.96–1.60 0.095 
45+ 35 13.0 0.84 0.60–1.17 0.30  0.84 0.60–1.18 0.32 
Trend:     0.86    0.89 
Night work in relation to first pregnancy, parous women only 
Parous but no night work 1593 586.5 1.00 Baseline  1.00 Baseline  
Started night work before 1
st
 58 41.3 1.00 0.77–1.31 0.99 0.95 0.73–1.25 0.73 
pregnancy 
Started night work after 1
st
 
 
111 
 
47.0 
 
0.97 
 
0.80–1.18 
 
0.75 
 
1.01 
 
0.83–1.23 
 
0.90 
pregnancy         
Time since last night shift work (years) 
None  1845 738.4 1.00 Baseline  1.00 Baseline  
Current  84 54.7 0.98 0.79–1.23 0.88 1.01 0.80–1.26 0.96 
0–<5  60 40.5 1.05 0.81–1.36 0.72 1.05 0.81–1.36 0.72 
5–<10  70 47.3 0.93 0.73–1.18 0.55 0.94 0.74–1.20 0.64 
 Trend§:     0.34   0.38 
HR: Hazard Ratio; CI: Confidence Interval 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am) 
† Number of breast cancer cases 
 
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 1960–69, 
1970–96); benign breast disease (yes, no); family history of breast cancer in 1st degree relatives (yes, no); socio-economic score (ACORN score as trend, missing); birth 
weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, missing); age at first pregnancy (trend, 
missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, no); alcohol consumption (never regular, trend curren t 
drinker 1-– <60g/day, current drinker 60+g/day, past drinker, drinker with unknown details); age started smoking (never, <17, 17_9, 20+, unknown); physical activity 
(log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, missing); menopausal hormone therapy use (never used, ex-user, current 
estrogen only user, current estrogen plus progestogen user, current user of other types, missing); menopausal status (pre- or post-menopausal) and age at menopause 
(trend, missing). 
 
§ Trend evaluated over those who have ceased night shift work, based on time-varying annually updated values 
  
SUPPLEMENTARY TABLE 1: Characteristics of incident invasive 
breast cancer cases arising in 102,869 women from the 
Generations  Study, 2004–2017  
Characteristic N % 
Age at breast cancer diagnosis (years)   
24–44 269 13.1 
45–54 536 26.0 
55–64 689 33.5 
65–74 471 22.9 
74–95 94 4.6 
Year of breast cancer diagnosis   
2004–2009 683 33.2 
2010–2014 1177 57.2 
2015–2017 199 9.7 
Confirmation of breast cancer   
Confirmed* 2041 99.1 
Self-reported only† 18 0.9 
Histological type   
Ductal 1611 78.2 
Lobular 337 16.4 
Mucinous or colloid 23 1.1 
Tubular 32 1.6 
Adenocarcinoma,  NOS 15 0.7 
Other named types 20 1.0 
Type unknown 21 1.0 
Estrogen receptor status   
Positive 1677 81.4 
Negative 313 15.2 
Type unknown 69 3.4 
Progesterone receptor status   
Positive 868 42.2 
Negative 432 21.0 
Type unknown 759 36.9 
Human epidermal growth factor receptor 2 status 
Positive 273 13.3 
Negative 1542 74.9 
Type unknown 273 11.9 
Total number of cases 2059 100.0 
* Confirmation through national cancer registration or medical 
records 
† Mostly with treatment or other details that implied breast 
cancer 
  
SUPPLEMENTARY TABLE 2: Relative risk of invasive breast cancer in relation to ever being a night shift worker* in last 10 
years, by frequency, intensity, and duration of night shift work in women who reported being in a paid or self-employed 
job, student, unemployed, or retired at recruitment 
 
Cases† 
Person-years Age adjusted Full adjustment‡ 
(per 100,000) HR 95% CI P -value HR 95% CI P -value 
Being a night shift worker within the last 10 years 
 
None 1574 636.5 1.00 Baseline  1.00 Baseline  
Yes 201 133.2 1.01 0.86–1.17 0.86 1.02 0.87–1.19 0.82 
Average hours worked per night 
None 1574 636.5 1.00 Baseline  1.00 Baseline  
<7 hours 86 61.7 1.09 0.88–1.36 0.44 1.08 0.87–1.35 0.49 
7+ hours 98 61.4 0.95 0.78–1.17 0.78 0.98 0.80–1.21 0.86 
Unknown 17 10.1 0.92 0.57–1.49 0.57 0.95 0.59–1.53 0.83 
Trend§:     0.39   0.53 
Average nights per week on night shift 
None 1574 636.5 1.00 Baseline  1.00 Baseline  
<4 144 99.1 0.97 0.81–1.15 0.72 0.98 0.82–1.17 0.84 
4–7 51 29.5 1.20 0.91–1.59 0.20 1.23 0.92–1.63 0.16 
Unknown 6 4.6 0.68 0.30–1.52 0.35 0.66 0.30–1.48 0.32 
Trend§:     0.058   0.052 
Average hours per week on night shift 
None 1574 636.5 1.00 Baseline  1.00 Baseline  
<10 67 52.9 0.92 0.72–1.18 0.31 0.92 0.71–1.172 0.49 
10–<20 57 36.4 1.07 0.82–1.40 0.67 1.09 0.83–1.43 0.53 
20–<30 33 19.4 1.04 0.73–1.47 0.90 1.07 0.75–1.51 0.72 
30+ 25 12.4 1.27 0.85–1.88 0.36 1.34 0.90–1.99 0.16 
Unknown 19 12.1 0.84 0.53–1.32 0.54 0.86 0.55–1.35 0.51 
Trend§:     0.03   0.027 
Cumulative years of employment as night shift worker 
None 1574 636.5 1.00 Baseline  1.00 Baseline  
<10 79 80.6 0.89 0.71–1.12 0.36 0.90 0.72–1.14 0.40 
10–<20 63 31.6 1.13 0.87–1.45 0.61 1.15 0.89–1.48 0.28 
20–<30 35 14.3 0.99 0.71–1.38 0.81 0.99 0.71–1.39 0.96 
30+ 24 6.7 1.18 0.78–1.76 0.59 1.18 0.79–1.77 0.43 
Trend§: 0.31 0.35 
Cumulative hours of night shift work (10,000 hours) 
 
None 1574 636.5 1.00 Baseline  1.00 Baseline  
0–<1 97 77.3 1.04 0.84–1.28 0.99 1.04 0.84–1.29 0.71 
1–<2 36 17.9 1.08 0.77–1.50 0.95 1.10 0.79–1.54 0.57 
2–<3 21 7.7 1.23 0.80–1.89 0.37 1.25 0.81–1.93 0.31 
3+ 20 7.0 1.06 0.68–1.65 0.84 1.08 0.70–1.69 0.72 
Unknown 27 23.2 0.73 0.50–1.07 0.16 0.75 0.51–1.09 0.13 
Trend§: 0.67 0.62 
HR: Hazard Ratio; CI: Confidence Interval 
 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am)? 
 
† Number of breast cancer cases 
  
 
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 
1960–69, 1970–96); benign breast disease (yes, no); family history of breast cancer in 1st degree relatives (yes, no); socio-economic score (ACORN score as 
trend, missing); birth weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, 
missing); age at first pregnancy (trend, missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, 
no); alcohol consumption (never regular, trend current drinker 1-– <60g/day, current drinker 60+g/day, past drinker, drinker with unknown details); age 
started smoking (never, <17, 17_9, 20+, unknown); physical activity (log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, 
missing); menopausal hormone therapy use (never used, ex-user, current estrogen only user, current estrogen plus progestogen user, current user of 
other types, missing); menopausal status (pre- or post-menopausal) and age at menopause (trend, missing). 
 
§ Trend evaluated over those doing night shift work, based on time-varying annually updated values 
  
SUPPLEMENTARY TABLE 3: Relative risk of invasive breast cancer in relation to ever being a night shift worker* in last 10 years, by   
type of work, age started, timing of first pregnancy, and time since last night shift work in women who reported being in a paid or self- 
employed job, student, unemployed, or retired at recruitment 
Person-years Age adjusted Full adjustment‡ 
Ca ses† 
(per 100,000) HR 95% CI P -value  HR 95% CI P -value 
Type of night shift work in last 10 years         
None 1574 636.5 1.00 Baseline   1.00 Baseline  
Nurse 81 48.6 0.86 0.69–1.08 0.19  0.88 0.71–1.11 0.29 
Waitress 9 23.0 0.60 0.31–1.17 0.13  0.61 0.32–1.20 0.15 
Office/shops 26 13.0 1.31 0.89–1.93 0.18  1.34 0.90–1.97 0.15 
Health Carer 19 8.2 1.27 0.81–2.00 0.29  1.40 0.89–2.21 0.15 
Technical 18 7.9 1.46 0.92–2.33 0.11  1.37 0.86–2.19 0.18 
Emergency services, armed 11 6.5 1.26 0.70–2.29 0.44  1.21 0.67–2.20 0.53 
forces, air crew          
Manual work 7 3.9 1.15 0.55–2.42 0.71  1.18 0.56–2.48 0.66 
Doctor/GP 7 8.1 0.88 0.42–1.86 0.74  0.82 0.39–1.72 0.59 
Other 23 14.0 1.07 0.71–1.62 0.74  1.05 0.69–1.58 0.83 
Heterogeneity:     0.30    0.33 
Age started night work (years)          
None 1574 636.5 1.00 Baseline   1.00 Baseline  
<25 68 68.9 1.05 0.82–1.36 0.68  1.06 0.82–1.37 0.64 
25–34 43 33.3 0.87 0.64–1.18 0.37  0.89 0.65–1.21 0.45 
35–44 59 18.9 1.25 0.96–1.62 0.096  1.27 0.98–1.65 0.074 
45+ 31 12.1 0.81 0.57–1.15 0.24  0.81 0.57–1.16 0.25 
Trend:     0.85    0.82 
Night work in relation to first pregnancy, parous women only 
Parous but no night work 1341 491.2 1.00 Baseline  1.00 Baseline  
Started night work before 1
st
 54 37.6 1.02 0.77–1.36 0.87 0.98 0.77–1.30 0.87 
pregnancy 
Started night work after 1
st
 
 
104 
 
42.7 
 
1.00 
 
0.82–1.22 
 
0.99 
 
1.04 
 
0.85–1.28 
 
0.70 
pregnancy         
Time since last night shift work (years) 
None  1574 636.5 1.00 Baseline  1.00 Baseline  
Current  82 52.1 1.03 0.82–1.29 0.78 1.05 0.84–1.32 0.66 
0–<5  56 37.9 1.06 0.81–1.39 0.65 1.06 0.81–1.39 0.65 
5–<10  63 43.3 0.93 0.72–1.20 0.56 0.94 0.73–1.22 0.66 
 Trend§:     0.21   0.25 
HR: Hazard Ratio; CI: Confidence Interval 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am) 
† Number of breast cancer cases 
 
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 1960–69, 
1970–96); benign breast disease (yes, no); family history of breast cancer in 1st degree relatives (yes, no); socio-economic score (ACORN score as trend, missing); birth 
weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, missing); age at first pregnancy (trend, 
missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, no); alcohol consumption (never regular, trend curren t 
drinker 1-– <60g/day, current drinker 60+g/day, past drinker, drinker with unknown details); age started smoking (never, <17, 17_9, 20+, unknown); physical activity 
(log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, missing); menopausal hormone therapy use (never used, ex-user, current 
estrogen only user, current estrogen plus progestogen user, current user of other types, missing); menopausal status (pre - or post-menopausal) and age at menopause 
(trend, missing). 
 
§ Trend evaluated over those who have ceased night shift work, based on time-varying annually updated values 
  
SUPPLEMENTARY TABLE 4: Relative risk of invasive breast cancer in relation to ever being a night shift worker* in last 10 years, 
stratified by risk factors for breast cancer, and ever use of melatonin supplements 
 
 
Cases† 
HR for night shift work within the last 10 years 
Person-years    
(per 100,000) Age adjusted Full adjustment‡ 
HR 95% CI P -value HR 95% CI P -value 
BMI at age 20 (kg/m2) (excludes missing and those <20 years of age) 
 
 
 
 
 
 
 
 
 
 
 
 
affluent 
affluent 
<22.5 1437 563.9 1.05 0.88–1.25 0.61 1.04 0.87–1.24 0.66 
;?22.5 557 278.8 0.88 0.68–1.15 0.36 0.90 0.69–1.17 0.44 
  Interaction:  P =0.29   P =0.36  
Family history of breast cancer 
None 1552 745.6 1.01 0.86–1.19 0.87 1.02 0.87–1.20 0.82 
Yes 507 135.3 0.90 0.66–1.23 0.51 0.92 0.67–1.25 0.58 
  Interaction:  P =0.50   P =0.55  
History of benign breast 
None 1448 713.1 0.91 0.76–1.08 0.29 0.93 0.78–1.11 0.42 
Yes 611 167.8 1.13 0.88–1.46 0.33 1.16 0.91–1.50 0.24 
  Interaction:  P =0.16   P =0.15  
Living in affluent neighbourhood 
More
 1019 380.0 1.10 0.88–1.37 0.41 1.11 0.89–1.38 0.36 
Less
 1040 500.8 0.92 0.76–1.11 0.37 0.92 0.76–1.11 0.38 
 
Parity 
Interaction:  P =0.22   P =0.20  
Nulliparous 297 
 
206.0 
 
0.98 
 
0.71–1.36 
 
0.91 
 
0.99 
 
0.71–1.37 
 
0.95 
Parous 1762 674.9 0.98 0.84–1.15 0.83 0.99 0.84–1.16 0.87 
 Interaction:  P =0.99   P =0.98  
Alcohol consumption 
Never 172 80.5 1.43 0.93–2.20 0.11 1.46 0.95–2.26 0.086 
Ever 1887 800.3 0.95 0.81–1.10 0.48 0.96 0.82–1.12 0.56 
  Interaction:  P =0.089   P =0.080  
Smoking cigarettes 
Never 1223 564.3 0.97 0.80–1.17 0.73 0.98 0.81–1.19 0.86 
Ever 836 316.6 0.98 0.79–1.21 0.85 1.01 0.82–1.26 0.90 
  Interaction:  P =0.92   P =0.83  
Physical activity (MET) § 
<50 979 432.7 0.98 0.79–1.23 0.88 1.00 0.80–1.25 0.99 
;?50 1078 446.8 0.98 0.82–1.19 0.87 0.99 0.82–1.20 0.93 
  Interaction:  P= 0.99   P =0.96  
Postmenopausal hormone therapy use (only among post-menopausal women) 
Never 830 275.8 1.10 0.86–1.42 0.44 1.12 0.87–1.43 0.39 
Ever 638 177.1 1.10 0.82–1.48 0.54 1.12 0.83–1.51 0.45 
  Interaction:  P =0.98   P =0.97  
Postmenopausal BMI (only among post-menopausal women) § 
<25 574 191.9 1.20 0.87–1.65 0.28 1.21 0.88–1.68 0.24 
;?25 679 193.5 1.07 0.81–1.41 0.64 1.12 0.85–1.48 0.43 
  Interaction:  P =0.61   P =0.71  
Ever used melatonin supplements before recruitment 
No 1968 852.2 0.96 0.82–1.11 0.57 0.97 0.84–1.13 0.71 
 
  
 
Yes 91 28.6 1.61 0.89–2.89 0.11 1.59 0.88–2.86 0.12 
  Interaction:  P =0.11   P =0.13  
HR: Hazard Ratio; CI: Confidence Interval; MET: Metabolic Equivalent to Task 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am)? 
† Number of breast cancer cases 
 
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 1960–
69, 1970–96); benign breast disease (yes, no); family history of breast cancer in 1st degree relatives (yes, no); socio-economic score (ACORN score as trend, 
missing); birth weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, missing); age at first 
pregnancy (trend, missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, no); alcohol consumption 
(never regular, trend current drinker 1-– <60g/day, current drinker 60+g/day, past drinker, drinker with unknown details); age started smoking (never, <17, 17_9, 
20+, unknown); physical activity (log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, missing); menopausal hormone therapy use 
(never used, ex-user, current estrogen only user, current estrogen plus progestogen user, current user of other types, missing); menopausal status (pre- or post- 
menopausal) and age at menopause (trend, missing); unless part of stratification variable 
 
§ Excludes strata for missing level of risk factor 
SUPPLEMENTARY TABLE 5: Relative risk of invasive breast cancer in relation to being a night shift worker* in last 10 years, by menopausal status and type of breast cancer 
 
 
Night shift work within 
the last 10 years† 
HR for night shift work within the 
last 10 years‡ 
 
Average hours per week on night shift‡ 
No Yes 
 
 
Yes vs No <10 10–<20 20–<30 30+ 
 
 
Trend§ 
       
Cases Cases HR 95% CI P-value HR 95% CI HR 95% CI HR      95% CI HR 95% CI P- value 
Menopausal status 
Pre- 494 97 0.88       0.70–1.09 0.24 0.65    0.44–0.95 1.13    0.80–1.60 1.03    0.64–1.68 0.89    0.46–1.73 0.92 
Post- 1351 117 1.10       0.91–1.34 0.31 1.12    0.82–1.52 0.97    0.66–1.44 1.06    0.66–1.69 1.58    0.98–2.56 0.099 
Interaction: P =0.12 P =0.13 
Estrogen Receptor (ER) Status 
0.25 
ER+ 1512 165 0.96       0.81–1.13 0.64 0.87    0.66–1.14 1.01    0.75–1.36 1.05    0.72–1.53 1.15    0.73–1.82 0.53 
ER- 276 37 1.02       0.72–1.43 0.93 1.02    0.60–1.75 1.14    0.62–2.07 1.09    0.48–2.47 1.45    0.60–3.51 0.40 
Unknown 57 12 1.82       0.89–3.74 0.10 (omitted: too few exposed cases for analysis) 
Interaction: P =0.23 P =0.96 
Progesterone Receptor (PR) Status 
0.64 
PR+ 771 97 1.04       0.84–1.30 0.71 0.98    0.69–1.39 1.13    0.77–1.65 0.69    0.37–1.29 1.45    0.84–2.53 0.24 
PR- 381 51 1.10       0.82–1.47 0.54 1.03    0.64–1.66 1.22    0.72–2.04 1.69    0.95–3.02 1.35    0.60–3.02 0.12 
Unknown 693 66 0.88       0.68–1.14 0.32 0.65    0.40–1.03 0.90    0.56–1.45 1.11    0.64–1.92 0.96    0.46–2.04 0.48 
Interaction: P =0.47 P =0.42 
Human Epidermal Growth Factor-Receptor 2 (HER2) Status 
0.24 
HER2+ 242 31 0.88       0.61–1.29 0.52 0.68    0.35–1.30 1.48    0.86–2.56 0.57    0.18–1.78 1.20    0.44–3.27 0.85 
HER2- 1384 158 1.02       0.86–1.21 0.82 0.98    0.74–1.28 0.93    0.67–1.28 1.24    0.86–1.79 1.21    0.76–1.93 0.27 
Unknown 219 25 1.00       0.65–1.54 0.99 0.53    0.22–1.30 1.35    0.69–2.63 0.51    0.13–2.05 1.64    0.61–4.44 0.81 
Histological sub-type 
Interaction: P =0.79 P =0.38 0.95 
Ductal 1439 172 0.99       0.85–1.17 0.95 0.82    0.62–1.08 1.17    0.89–1.54 1.01    0.69–1.48 1.09    0.68–1.74 0.47 
Lobular 301 36 1.24       0.87–1.78 0.24 1.52    0.91–2.55 0.66    0.27–1.60 1.52    0.72–3.23 2.14    0.95–4.83 0.072 
Other 105 6 0.45       0.20–1.04 0.062 (omitted: too few exposed cases for analysis) 
Interaction: P =0.087 P =0.075 
HR: Hazard Ratio; CI: Confidence Interval 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am)? 
† Number of breast cancer cases 
0.20 
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 1960–69, 1970–96); benign breast disease (yes, no); family history of breast cancer in 
1st degree relatives (yes, no); socio-economic score (ACORN score as trend, missing); birth weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, missing); age at first 
pregnancy (trend, missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, no); alcohol consumption (never regular, trend current drinker 1-– <60g/day, current drinker 60+g/day, past 
drinker, drinker with unknown details); age started smoking (never, <17, 17_9, 20+, unknown); physical activity (log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, missing); menopausal hormone therapy 
use (never used, ex-user, current estrogen only user, current estrogen plus progestogen user, current user of other types, missing); age at menopause (trend, missing), and for analyses by receptor status and histological sub-type,  
menopausal status (pre- or post-menopausal). 
§  Trend evaluated over those doing night shift work, based on time-varying annually updated values (excludes missing hours per week) 
SUPPLEMENTARY TABLE 6: Relative risk of invasive breast cancer in relation to being a night shift worker* in last 10 years, by type of breast cancer and menopausal status 
 
 
Night shift work within 
the last 10 years† 
HR for night shift work within the 
last 10 years‡ 
 
Average hours per week on night  shift‡ 
No Yes 
 
 
Yes vs No <10 10–<20 20–<30 30+ 
 
 
Trend§ 
       
Cases Cases HR 95% CI P-value HR       95% CI HR 95% CI HR 95% CI HR 95% CI P- value 
Estrogen Receptor (ER)  Status 
Pre-menopausal women 
ER+ 394 70 0.81      0.62–1.04 0.099 0.57    0.36–0.90 1.04     0.69–1.56 1.15      0.69–1.94 0.50     0.19–1.36 0.27 
ER- 81 24 1.18      0.75–1.84 0.48 1.12    0.57–2.22 1.59     0.80–3.17 0.68      0.17–2.76 1.61     0.51–5.05 0.63 
Unknown 19 3 0.62      0.17–2.31 0.48 (omitted: too few exposed cases for  analysis) 
Post-menopausal women 
Interaction: P =0.31 P =0.19 0.96 
ER+ 1118 95 1.12      0.90–1.39 0.30 1.19    0.85–1.66 0.97     0.63–1.50 0.97      0.56–1.68 1.77     1.06–2.96 0.078 
ER- 195 13 0.85      0.49–1.49 0.57 0.91    0.38–2.19 0.52     0.13–2.10 1.66      0.62–4.46 1.30     0.32–5.27 0.93 
Unknown 38 9 3.68      1.77–7.66 <0.001 (omitted: too few exposed cases for  analysis) 
Interaction: P =0.0045 P =0.73 
Progesterone Receptor (PR) Status 
Pre-menopausal women 
0.57 
PR+ 235 38 0.72      0.51–1.03 0.069 0.59    0.33–1.05 1.03     0.61–1.73 0.51      0.19–1.38 0.41     0.10–1.67 0.18 
PR- 98 28 1.15      0.76–1.73 0.52 0.94    0.48–1.84 1.47     0.77–2.83 1.41      0.57–3.45 1.78     0.66–4.83 0.37 
Unknown 161 31 0.88      0.60–1.30 0.52 0.51    0.24–1.09 1.03     0.54–1.95 1.50      0.73–3.07 0.93     0.30–2.96 0.86 
 
Post-menopausal women 
Interaction: P =0.25 P =0.42 0.66 
PR+ 536 59 1.41      1.07–1.87 0.015 1.46    0.95–2.25 1.21     0.70–2.11 0.90      0.40–2.03 2.64     1.44–4.82 0.0044 
PR- 283 23 1.07      0.70–1.63 0.75 1.17    0.60–2.25 0.92     0.38–2.23 2.07      0.98–4.38 0.93     0.23–3.74 0.44 
Unknown 532 35 0.89      0.63–1.26 0.53 0.79    0.43–1.43 0.80     0.40–1.62 0.81      0.34–1.97 1.02     0.38–2.74 0.66 
Interaction: P =0.12 P =0.24 
Human Epidermal Growth Factor-Receptor 2 (HER2) Status 
Pre-menopausal women 
0.13 
HER2+ 86 21 0.97      0.60–1.57 0.91 0.59    0.25–1.41 1.83     0.97–3.46 0.64      0.16–2.60 1.52     0.47–4.87 0.89 
HER2- 348 62 0.79      0.60–1.04 0.094 0.63    0.40–0.99 0.88     0.55–1.39 1.11      0.64–1.94 0.56     0.21–1.49 0.18 
Unknown 60 14 1.12      0.61–2.04 0.72 0.82    0.29–2.31 1.44     0.58–3.57 1.03      0.25–4.29 1.73     0.42–7.17 0.33 
Post-menopausal women 
Interaction: P =0.52 P =0.56 0.80 
HER2+ 156 10 0.77      0.40–1.46 0.42 0.85    0.32–2.26 0.90     0.29–2.86 0.48      0.07–3.49 0.77     0.11–5.55 0.96 
HER2- 1036 96 1.24      1.00–1.54 0.048 1.32    0.95–1.84 0.95     0.60–1.51 1.39      0.86–2.25 1.81     1.07–3.08 0.016 
Unknown 159 11 0.92      0.49–1.72 0.80 (omitted: too few exposed cases for  analysis) 
Histological sub-type 
Pre-menopausal women 
Interaction: P =0.29 P =0.68 0.46 
Ductal 403 84 0.90      0.71–1.14 0.39 0.66    0.44–0.99 1.20     0.83–1.73 0.94      0.54–1.63 0.92     0.46–1.87 0.19 
Lobular 59 9 0.76      0.37–1.53 0.44 
Other 32 4 0.55      0.19–1.61 0.28 
Interaction: P =0.63 
(omitted: too few exposed cases for analysis) 
(omitted: too few exposed cases for  analysis) 
Post-menopausal women 
Ductal 1036 88 1.08      0.87–1.35 0.49 1.02    0.70–1.47 1.13     0.75–1.71 1.11      0.65–1.88 1.24     0.66–2.33 0.26 
Lobular 242 27 1.54      1.03–2.32 0.037 1.96    1.08–3.54 0.68     0.22–2.13 1.48      0.55–4.00 3.52     1.56–7.95 0.0053 
Other 73 2 0.34      0.08–1.37 0.13 (omitted: too few exposed cases for  analysis) 
Interaction: P =0.073 P =0.090 
HR: Hazard Ratio; CI: Confidence Interval 
* Night shift work: Over the last ten years, have you had any jobs that regularly involved work in the late evening or night (between 10pm and 7am)? 
† Number of breast cancer cases 
0.079 
 
‡ HR adjusted for: attained age (Cox regression time scale); time since recruitment to cohort (0, 1–2, 3+ years); birth cohort (1908–39, 1940–49, 1950–59, 1960–69, 1970–96); benign breast disease (yes, no); family history of breast cancer in 1st degree 
relatives (yes, no); socio-economic score (ACORN score as trend, missing); birth weight (trend, missing); height at age 20 (trend, missing); age at menarche (trend, missing); body mass index at age 20 (trend, missing); age at first pregnancy (trend, 
missing); parity (trend, missing); breast-feeding (yes/no); current oral contraceptive use before menopause (yes, no); alcohol consumption (never regular, trend current drinker 1-– <60g/day, current drinker 60+g/day, past drinker, drinker with 
unknown details); age started smoking (never, <17, 17_9, 20+, unknown); physical activity (log(metabolic equivalent) trend, missing ); post-menopausal body mass index (trend, missing); menopausal hormone therapy use (never used, ex-user, 
current estrogen only user, current estrogen plus progestogen user, current user of other types, missing); menopausal status (pre- or post-menopausal) and age at menopause (trend, missing). 
 
§ Trend evaluated over those doing night shift work, based on time-varying annually updated values (excludes missing hours per week) 
